U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
172891172891Chemoembolization Using Doxorubicin in Treating Patients With Liver Cancer That Cannot Be Removed By SurgeryCompletedNo Results AvailableLiver CancerDevice: doxorubicin hydrochloridehttps://ClinicalTrials.gov/show/NCT00293397
172892172892Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell TransplantCompletedHas ResultsBreast Cancer|Chronic Myeloproliferative Disorders|Gestational Trophoblastic Tumor|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms|Nausea and Vomiting|Neuroblastoma|OvarianDrug: Aprepitant|Drug: Cyclophosphamide|Drug: Dexamethasone|Drug: Granisetron hydrochloridehttps://ClinicalTrials.gov/show/NCT00293384
172893172893Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate CancerTerminatedNo Results AvailableProstate CancerDrug: docetaxel|Drug: prednisone|Drug: vatalanibhttps://ClinicalTrials.gov/show/NCT00293371
172894172894Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the BrainCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: carboplatin|Drug: cisplatin|Drug: etoposide phosphate|Drug: ifosfamide|Procedure: adjuvant therapy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00293358
1728951728953-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNo Results AvailableAnaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Primary Central Nervous System Hodgkin Lymphoma|PrimarDrug: gemcitabine hydrochloride|Drug: triapinehttps://ClinicalTrials.gov/show/NCT00293345
172896172896Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By SurgeryTerminatedNo Results AvailableLung CancerBiological: bevacizumab|Drug: carboplatin|Drug: docetaxel|Procedure: conventional surgeryhttps://ClinicalTrials.gov/show/NCT00293332
172897172897131 I-MIBG in Treating Patients With Refractory or Relapsed NeuroblastomaCompletedNo Results AvailableNeuroblastomaBiological: filgrastim|Radiation: iobenguane I 131https://ClinicalTrials.gov/show/NCT00293319
172898172898Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative MedicineCompletedHas ResultsOvarian Cancer|Peritoneal Primary Cancer|Fallopian Tube CancerOther: healing touch|Other: massage therapy|Other: hypnosis|Drug: Standard chemotherapyhttps://ClinicalTrials.gov/show/NCT00293293
172899172899Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: lomustinehttps://ClinicalTrials.gov/show/NCT00293280
172900172900A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (MK0518-018 EXT2)CompletedHas ResultsHIV InfectionsDrug: raltegravir potassium|Drug: Comparator: Placebohttps://ClinicalTrials.gov/show/NCT00293267
172901172901A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (0518-019)CompletedHas ResultsHIV InfectionsDrug: raltegravir potassium|Drug: Comparator: placebohttps://ClinicalTrials.gov/show/NCT00293254
172902172902PreFER Managed Ventricular Pacing (MVP) For Elective ReplacementCompletedHas ResultsCardiovascular DiseasesDevice: Managed Ventricular Pacing programmed ON/OFFhttps://ClinicalTrials.gov/show/NCT00293241
172903172903Treatment of Latent Tuberculosis Infection With IsoniazidCompletedNo Results AvailableTuberculosisDrug: Isoniazid|Drug: isoniazidhttps://ClinicalTrials.gov/show/NCT00293228
172904172904Biodistribution Study of CMD-193 in Patients With Advanced Tumours Expressing the Lewis-Y AntigenCompletedNo Results AvailableNeoplasmsDrug: 111-Indium-CMD-193|Drug: CMD-193https://ClinicalTrials.gov/show/NCT00293215
172905172905Safety and Efficacy Study of the Effect of Etanercept in Hemodialysis PatientsTerminatedNo Results AvailableEnd Stage Renal DiseaseDrug: Etanercept|Drug: Salinehttps://ClinicalTrials.gov/show/NCT00293202
172906172906Gene-Polymorphies in the P2X7 Gene in Patients With Osteoporotic FracturesRecruitingNo Results AvailableHip Fracturehttps://ClinicalTrials.gov/show/NCT00293189
172907172907The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)CompletedNo Results AvailableMemory LossDrug: Donepezil Hydrochloride|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00293176
172908172908A Post-Market Study to Evaluate Adverse Event Incidence Rates in Patients With Skin of Color Undergoing Correction of Nasolabial Folds With Hylaform, Hylaform Plus and Captique.CompletedNo Results AvailableFacial WrinklesDevice: Hylaform, Hylaform Plus (hylan B gel)https://ClinicalTrials.gov/show/NCT00293163
172909172909PREDICT: Eplerenone in Reversing Endothelial and Diastolic Dysfunction and Improving Collagen Turnover in Diastolic Heart FailureCompletedNo Results AvailableDiastolic Heart FailureDrug: eplerinonehttps://ClinicalTrials.gov/show/NCT00293150
172910172910NORDIC: Nitric Oxide-Derived Oxidants and Regional Endothelial and Diastolic Dysfunction in Dilated CardiomyopathyTerminatedNo Results AvailableChronic Systolic Heart Failure (Dilated Cardiomyopathy)https://ClinicalTrials.gov/show/NCT00293137
172911172911Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal TumorsCompletedNo Results AvailableGastrointestinal Stromal TumorsDrug: Glivechttps://ClinicalTrials.gov/show/NCT00293124
172912172912Safety and Efficacy of SDX-101 (R-Etodolac) in Patients With Relapsed or Refractory Multiple Myeloma (MM)TerminatedNo Results AvailableMultiple MyelomaDrug: SDX-101 (R-Etodolac)https://ClinicalTrials.gov/show/NCT00293111
172913172913Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart DiseaseApproved for marketingNo Results AvailableIron OverloadDrug: deferipronehttps://ClinicalTrials.gov/show/NCT00293098
172914172914An Open, Randomized, Multicentre, Phase II Pilot StudyCompletedNo Results AvailableNon-Small Cell Lung CancerDrug: Docetaxel|Drug: Docetaxelhttps://ClinicalTrials.gov/show/NCT00293085
172915172915Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and VasculitisCompletedNo Results AvailableSystemic Lupus Erythematosus|ANCA Associated VasculitisDrug: Rituximabhttps://ClinicalTrials.gov/show/NCT00293072
172916172916Efficacy and Safety Study for the Treatment of Dysfunctional Uterine BleedingCompletedHas ResultsMetrorrhagiaDrug: Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00293059
172917172917Assessment of Grazax® Treatment ComplianceCompletedNo Results AvailableAllergyBiological: ALK Grass tablet - use of compliance devicehttps://ClinicalTrials.gov/show/NCT00293046
172918172918Study of BEMAâ„¢ Fentanyl in the Treatment of Breakthrough Pain in Cancer SubjectsCompletedNo Results AvailablePain|CancerDrug: BEMAâ„¢ Fentanylhttps://ClinicalTrials.gov/show/NCT00293033
172919172919Study of the Safety of BEMAâ„¢ Fentanyl Use for Breakthrough Pain in Cancer Subjects on Chronic Opioid TherapyCompletedHas ResultsPain|CancerDrug: BEMA Fentanylhttps://ClinicalTrials.gov/show/NCT00293020
172920172920Study of How Exercise or Weight Loss Effects Metabolic SyndromeActive, not recruitingNo Results AvailableMetabolic Syndrome|Insulin Resistance|ObesityBehavioral: Exercise|Behavioral: Weight Losshttps://ClinicalTrials.gov/show/NCT00292994

* Görseller ve İçerik tekif hakkına sahip olabilir